28
Apr
EssilorLuxottica has introduced its Essilor® Stellest® lens in India, marking the arrival of what the company says is the first and only U.S. FDA market-authorized spectacle lens designed to slow myopia progression in children. The announcement comes amid growing concerns over rising cases of childhood myopia in India, where nearly 50 per cent of urban children are projected to be affected by 2050, while one in four children already suffers from the condition. The company said clinical studies showed the Essilor® Stellest® lens slowed myopia progression by 71 per cent on average over two years. The lens received U.S. FDA…
